Measles vaccine

BIOLOGICAL13 trials

Conditions

BCG Vaccination ReactionChild MorbidityChild MortalityChildrenDiphtheriaHealthy VolunteersHepatitis AHospital Admission

Phase 3

Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)

GlaxoSmithKlineMalaria, Malaria Vaccines

Start: 2011-11-17End: 2017-02-09Updated: 2019-07-18

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

CompletedNCT05794230

Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers, Meningococcal Immunisation

Start: 2023-03-27End: 2025-11-15Updated: 2026-01-21

Phase 4

Long-term Follow-up of Measles Antibodies

CompletedNCT00168571

Bandim Health ProjectMeasles

Start: 2002-03-31End: 2007-01-31Target: 1960Updated: 2011-09-22

Immunology of Non-specific Effects of Vaccine

CompletedNCT00168545

Bandim Health ProjectDiphtheria, Measles, Pertussis +1

Start: 2006-01-31End: 2007-01-31Target: 400Updated: 2011-09-22

Early Two-dose Measles Vaccination Trial

CompletedNCT00168558

Bandim Health ProjectMeasles

Start: 2003-07-31End: 2008-03-31Updated: 2012-03-06

Additional Measles Vaccine at 4 Months of Age

NCT01486355

Bandim Health ProjectMeasles Infection

Start: 2011-08-31Updated: 2013-11-15

Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine

NCT03330171

University of Witwatersrand, South AfricaHepatitis A, Measles, Varicella

Start: 2017-04-10End: 2022-12-01Updated: 2020-03-17

Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children

CompletedNCT03460002

Bandim Health ProjectChildren, Measles Vaccination, Morbidity +3

Start: 2016-11-30End: 2022-08-31Updated: 2024-09-03

Measles Vaccination at Health System Contacts

Enrolling by invitationNCT04220671

Bandim Health ProjectHospital Admission, Measles Vaccine, Mortality +1

Start: 2020-01-08End: 2027-06-30Target: 5400Updated: 2025-07-29

Measles and BCG Vaccines for Mother and Child

RecruitingNCT04899765

Bandim Health ProjectBCG Vaccination Reaction, Measles, Mother-Infant Interaction +1

Start: 2021-05-20End: 2027-12-31Target: 2400Updated: 2024-01-19

Unknown Phase

Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia

CompletedNCT02058927

University of North Carolina, Chapel HillMeasles

Start: 2011-05-31End: 2012-02-29Updated: 2014-09-18

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

CompletedNCT02943681

Bandim Health ProjectChild Morbidity, Child Mortality

Start: 2016-10-31End: 2021-05-31Updated: 2024-01-19

Randomized Controlled Trial of Measles Vaccination Schedule

NCT03170765

Post Graduate Institute of Medical Education and Research, ChandigarhMEASLES DISEASE

Start: 2017-03-14End: 2018-05-31Target: 120Updated: 2017-05-31

Vaccine2024-04-173 citations

Effect of early two-dose measles vaccination on childhood mortality and modification by maternal measles antibody in Guinea-Bissau, West Africa: A single-centre open-label randomised controlled trial.

2022-05-2718 citations

Health effects of utilising hospital contacts to provide measles vaccination to children 9-59 months-a randomised controlled trial in Guinea-Bissau.

2022-04-231 citations

The Effect of a Second Dose of Measles Vaccine at 18 Months of Age on Nonaccidental Deaths and Hospital Admissions in Guinea-Bissau: Interim Analysis of a Randomized Controlled Trial

Clinical Infectious Diseases2022-02-2511 citations

Reduction in Short-term Outpatient Consultations After a Campaign With Measles Vaccine in Children Aged 9–59 Months: Substudy Within a Cluster-Randomized Trial

Journal of the Pediatric Infectious Diseases Society2020-07-146 citations

Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children.

2020-04-16

Research protocol of two concurrent cluster-randomized trials: Real-life Effect of a CAMPaign with Measles Vaccination (RECAMP-MV) and Real-life Effect of a CAMPaign with Oral Polio Vaccination (RECAMP-OPV) on mortality and morbidity among children in rural Guinea-Bissau

BMC Public Health2019-11-118 citations

Immunogenicity and Safety of an Early Measles Vaccination Schedule at 6 and 12 Months of Age in Human Immunodeficiency Virus (HIV)–Unexposed and HIV-Exposed, Uninfected South African Children

The Journal of Infectious Diseases2019-07-0411 citations

Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial

Human Vaccines & Immunotherapeutics2018-04-0924 citations

Effect of early measles vaccine on pneumococcal colonization: A randomized trial from Guinea-Bissau

PLoS ONE2017-05-1719 citations

Randomized Trial of 2 Versus 1 Dose of Measles Vaccine: Effect on Hospital Admission of Children After 9 Months of Age

Journal of the Pediatric Infectious Diseases Society2017-05-1112 citations

The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau

BMC Pediatrics2016-12-0133 citations

Measles Vaccination in the Presence or Absence of Maternal Measles Antibody: Impact on Child Survival

Clinical Infectious Diseases2014-05-14110 citations

Measles Virus Antibody Responses in Children Randomly Assigned to Receive Standard-Titer Edmonston-Zagreb Measles Vaccine at 4.5 and 9 Months of Age, 9 Months of Age, or 9 and 18 Months of Age

The Journal of Infectious Diseases2014-03-3126 citations

The effect of early measles vaccination on thymic size. A randomized study from Guinea-Bissau.

2014-02-091 citations

A Randomized Trial of a Standard Dose of Edmonston-Zagreb Measles Vaccine Given at 4.5 Months of Age: Effect on Total Hospital Admissions

The Journal of Infectious Diseases2014-01-1687 citations

Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.

2010-11-30219 citations

Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.

2008-07-2458 citations

Measles vaccine

Sponsors

Conditions

Phase 3

Phase 4

Unknown Phase

Related Papers